Atlas Trials

A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia

Clinical trial NCT07681089 · RECRUITING

Trial details

NCT number
NCT07681089
Sponsor
Kiminori Kimura, MD
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Liver Cirrhosis
Start date
2026-09-01
Primary completion
2027-11-30
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.